Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jack

Showing results (841-850 of 1,303) with videos related to

Pageof 131
Sort By:
Neurology|October 15, 2017
Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkersRosebud O Roberts, David S Knopman, Jeremy A Syrjanen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2015
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concernShannon L Risacher, Sungeun Kim, Kwangsik Nho, et al.
Brain : a Journal of Neurology|July 26, 2016
Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodiesLidia Sarro, Matthew L Senjem, Emily S Lundt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2022
The Overlap Index as a Means of Evaluating Early Tau PET Signal ReliabilityJeyeon Lee, Brian J Burkett, Hoon-Ki Min, et al.
The Lancet. Neurology|May 1, 2017
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional studyClifford R Jack, Heather J Wiste, Stephen D Weigand, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 11, 2020
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Maria Vassilaki, et al.
Neurology|August 27, 2017
<sup>1</sup>H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adultsZuzana Nedelska, Scott A Przybelski, Timothy G Lesnick, et al.
Brain and Language|August 17, 2019
Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasiaRene L Utianski, Hugo Botha, Peter R Martin, et al.
Neurobiology of Aging|April 8, 2014
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal personsDavid S Knopman, Clifford R Jack, Heather J Wiste, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 30, 2023
Significance of a positive tau PET scan with a negative amyloid PET scanCarling G Robinson, Jeyeon Lee, Paul H Min, et al.
Pageof 131

Showing results (841-850 of 1,303) with videos related to

Sort By:
Pageof 131
Neurology|October 15, 2017
Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkersRosebud O Roberts, David S Knopman, Jeremy A Syrjanen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2015
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concernShannon L Risacher, Sungeun Kim, Kwangsik Nho, et al.
Brain : a Journal of Neurology|July 26, 2016
Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodiesLidia Sarro, Matthew L Senjem, Emily S Lundt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2022
The Overlap Index as a Means of Evaluating Early Tau PET Signal ReliabilityJeyeon Lee, Brian J Burkett, Hoon-Ki Min, et al.
The Lancet. Neurology|May 1, 2017
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional studyClifford R Jack, Heather J Wiste, Stephen D Weigand, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 11, 2020
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Maria Vassilaki, et al.
Neurology|August 27, 2017
<sup>1</sup>H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adultsZuzana Nedelska, Scott A Przybelski, Timothy G Lesnick, et al.
Brain and Language|August 17, 2019
Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasiaRene L Utianski, Hugo Botha, Peter R Martin, et al.
Neurobiology of Aging|April 8, 2014
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal personsDavid S Knopman, Clifford R Jack, Heather J Wiste, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 30, 2023
Significance of a positive tau PET scan with a negative amyloid PET scanCarling G Robinson, Jeyeon Lee, Paul H Min, et al.
Pageof 131